Deficiency of SARS-CoV-2 T-cell responses after vaccination in long-term allo-HSCT survivors translates into abated humoral immunity

Recipients of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for hematological diseases are at risk of severe disease and death from COVID-19. To determine the safety and immunogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines, samples from 50 infection-naive allo-HSCT recipients...

Descripción completa

Detalles Bibliográficos
Autores principales: Einarsdottir, Sigrun, Martner, Anna, Waldenström, Jesper, Nicklasson, Malin, Ringlander, Johan, Arabpour, Mohammad, Törnell, Andreas, Wiktorin, Hanna Grauers, Nilsson, Staffan, Bittar, Rudy, Nilsson, Malin, Lisak, Mikael, Veje, Malin, Friman, Vanda, Al-Dury, Samer, Bergström, Tomas, Ljungman, Per, Brune, Mats, Hellstrand, Kristoffer, Lagging, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923719/
https://www.ncbi.nlm.nih.gov/pubmed/35286374
http://dx.doi.org/10.1182/bloodadvances.2021006937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923719/
https://www.ncbi.nlm.nih.gov/pubmed/35286374
http://dx.doi.org/10.1182/bloodadvances.2021006937

Ejemplares similares